Lactose Anhydrous
Lactose Anhydrous is known as a directly compressible tablet excipient, dry powder inhaler carrier, lyophilization aid, tablet and capsule diluent, tablet and capsule filler. Lactose Anhydrous is one of the ingredients in Arvin Kala’s diverse product portfolio.

Description

Anhydrous lactose appears as white to off-white crystalline particles or powder. Various commercial brands of anhydrous lactose are available, containing both anhydrous β-lactose and anhydrous α-lactose. Typically, anhydrous lactose consists of 70 to 80% anhydrous β-lactose and 20 to 30% anhydrous α-lactose.
The structural form of Lactose Anhydrous is as follows:

Applications in Pharmaceutical Formulation or Technology
Anhydrous lactose is extensively utilized in direct compression tableting, serving as a filler and binder for tablets and capsules. Its low moisture content makes it suitable for use with moisture-sensitive drugs. Additionally, anhydrous lactose can be employed in intravenous injections.

Stability and Storage Conditions

Mold growth can occur in humid conditions (80% RH and above). Lactose may turn brown during storage, especially in warm, damp environments. At 80°C and 80% RH, tablets containing anhydrous lactose have been observed to expand 1.2 times after one day. Anhydrous lactose should be stored in a well-sealed container in a cool, dry place.
Method of Manufacture
There are two anhydrous forms of lactose: α-lactose and β-lactose. The ratio of these forms is influenced by the temperature during crystallization. Commercially available anhydrous lactose can be hygroscopic at high relative humidities. It is produced by roller drying a lactose solution at temperatures above 93.5°C, followed by milling and sieving. Special drying techniques can produce two types of anhydrous α-lactose: one that is unstable and hygroscopic, and another that has good compaction properties. However, these specific materials are not commercially available.
Safety
Lactose is commonly utilized in pharmaceutical formulations as a diluent and filler-binder for oral capsules and tablets. It can also be used in intravenous injections. Adverse reactions to lactose are primarily due to lactose intolerance, which occurs in individuals lacking the intestinal enzyme lactase. This intolerance is typically associated with consuming amounts of lactose far exceeding those found in solid dosage forms.
Handling Precautions
Follow standard safety precautions based on the specific situation and amount of material being handled. Avoid generating excessive dust or inhaling it.
Typical Properties

Brittle fracture index 0.0362

Bonding index 0.0049 (at compression pressure 177.8 MPa)

Density (true) 1.589 g/cm3 for anhydrous b-lactose

Density (bulk) 0.71 g/cm3 for SuperTab 21AN; 0.66 g/cm3 for Super-Tab 22AN.

Density (tapped) 0.88 g/cm3 for SuperTab 21AN; 0.78 g/cm3 for Super-Tab 22AN.

Melting point 223.08C for anhydrous a-lactose; 252.28C for anhydrous b-lactose; 232.08C (typical) for commercial anhydrous lactose.

Permanent deformation pressure 521.0MPa (at compression pressure 177.8 MPa)

Solubility Soluble in water; sparingly soluble in ethanol (95%) and ether; 40 g/100 mL at 258C for typical Sheffield Pharma Ingredients products.

Chemical-physical values

Test Item Unit Specification
Residue on ignition
%
NMT 0.1
Content of alpha anomer
%
reporting
Content of beta anomer
%
reporting
Prarticle size distribution < 45 µm
%
NMT 20
Particle size distribution < 150 µm
%
NLT 40 NMT 65
Particle size distribution < 250 µm
%
NLT 80
Test Item Unit Specification
Protein and light absorbing impurities in the range ol 210 – 220 nm
NMT 0.25
Acidity or alkalinity
ml
NMT 0.4
Optical rotation (specific rotation) calculated on the anhydrous basis
%
NMT 55.9
NLT 54.4
Water determination
%
NMT 1.0
Loss on drying
%
NMT 0.5

We look forward to your call with great anticipation.

Thank you for choosing Arvin Kala.